Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in JapanTakashi Taga, Souichi Adachi, Akitoshi Kinoshita et al.|Pediatric Blood & Cancer|2015Cited by 48
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Daisuke Tomizawa, Shiro Tanaka et al.|Leukemia|2021Cited by 19
High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemiaDaisuke Tomizawa, Souichi Adachi, Jun Matsubayashi et al.|Leukemia|2023Cited by 8
High <i>IL2RA</i>/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core‐binding factorTakahiro Aoki, Daisuke Tomizawa, Norio Shiba et al.|Pediatric Blood & Cancer|2023Cited by 7
Correction to: Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndromeTakashi Taga, Daisuke Tomizawa, Shiro Tanaka et al.|Leukemia|2021Cited by 4